| SARS-CoV-2 spike E484K mutation reduces antibody neutralisation S Jangra, C Ye, R Rathnasinghe, D Stadlbauer, H Alshammary, ... The Lancet Microbe 2 (7), e283-e284, 2021 | 433 | 2021 |
| Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A KM White, R Rosales, S Yildiz, T Kehrer, L Miorin, E Moreno, S Jangra, ... Science 371 (6532), 926-931, 2021 | 332 | 2021 |
| Drug-induced phospholipidosis confounds drug repurposing for SARS-CoV-2 TA Tummino, VV Rezelj, B Fischer, A Fischer, MJ O’meara, B Monel, ... Science 373 (6554), 541-547, 2021 | 189 | 2021 |
| The E484K mutation in the SARS-CoV-2 spike protein reduces but does not abolish neutralizing activity of human convalescent and post-vaccination sera. S Jangra, C Ye, R Rathnasinghe, D Stadlbauer, F Krammer, V Simon, ... MedRxiv, 2021 | 152 | 2021 |
| The N501Y mutation in SARS-CoV-2 spike leads to morbidity in obese and aged mice and is neutralized by convalescent and post-vaccination human sera R Rathnasinghe, S Jangra, A Cupic, C Martínez-Romero, LCF Mulder, ... MedRxiv, 2021 | 119 | 2021 |
| TOP1 inhibition therapy protects against SARS-CoV-2-induced lethal inflammation JSY Ho, BWY Mok, L Campisi, T Jordan, S Yildiz, S Parameswaran, ... Cell 184 (10), 2618-2632. e17, 2021 | 100 | 2021 |
| A Newcastle disease virus expressing a stabilized spike protein of SARS-CoV-2 induces protective immune responses W Sun, Y Liu, F Amanat, I González-Domínguez, S McCroskery, ... Nature communications 12 (1), 6197, 2021 | 85 | 2021 |
| Epstein–Barr virus and innate immunity: friends or foes? S Jangra, KS Yuen, MG Botelho, DY Jin Microorganisms 7 (6), 183, 2019 | 72 | 2019 |
| SARS-CoV-2 infection triggers pro-atherogenic inflammatory responses in human coronary vessels N Eberhardt, MG Noval, R Kaur, L Amadori, M Gildea, S Sajja, D Das, ... Nature cardiovascular research 2 (10), 899-916, 2023 | 68 | 2023 |
| Sterilizing immunity against SARS‐CoV‐2 infection in mice by a single‐shot and lipid amphiphile imidazoquinoline TLR7/8 agonist‐adjuvanted recombinant spike protein vaccine S Jangra, J De Vrieze, A Choi, R Rathnasinghe, G Laghlali, A Uvyn, ... Angewandte Chemie International Edition 60 (17), 9467-9473, 2021 | 65 | 2021 |
| Impact of SARS-CoV-2 ORF6 and its variant polymorphisms on host responses and viral pathogenesis T Kehrer, A Cupic, C Ye, S Yildiz, M Bouhaddou, NA Crossland, ... Cell Host & Microbe 31 (10), 1668-1684. e12, 2023 | 59 | 2023 |
| Limited extent and consequences of pancreatic SARS-CoV-2 infection V van der Heide, S Jangra, P Cohen, R Rathnasinghe, S Aslam, T Aydillo, ... Cell reports 38 (11), 2022 | 57 | 2022 |
| COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical models P Maisonnasse, Y Aldon, A Marc, R Marlin, N Dereuddre-Bosquet, ... Nature communications 12 (1), 6097, 2021 | 50 | 2021 |
| The virucidal effects of 405 nm visible light on SARS-CoV-2 and influenza A virus R Rathnasinghe, S Jangra, L Miorin, M Schotsaert, C Yahnke, ... Scientific Reports 11 (1), 19470, 2021 | 45 | 2021 |
| SARS-CoV-2 spike E484K mutation reduces antibody neutralisation. Lancet Microbe 2: e283–e284 S Jangra, C Ye, R Rathnasinghe, D Stadlbauer, F Krammer, V Simon, ... | 40 | 2021 |
| Characterization of SARS-CoV-2 Spike mutations important for infection of mice and escape from human immune sera R Rathnasinghe, S Jangra, C Ye, A Cupic, G Singh, C Martínez-Romero, ... Nature Communications 13 (1), 3921, 2022 | 34 | 2022 |
| A combination adjuvant for the induction of potent antiviral immune responses for a recombinant SARS-CoV-2 protein vaccine S Jangra, JJ Landers, R Rathnasinghe, JJ O’Konek, KW Janczak, ... Frontiers in Immunology 12, 729189, 2021 | 34 | 2021 |
| Scalable, effective, and rapid decontamination of SARS-CoV-2 contaminated N95 respirators using germicidal ultraviolet C (UVC) irradiation device R Rathnasinghe, RF Karlicek Jr, M Schotsaert, M Koffas, BL Arduini, ... Scientific Reports 11 (1), 19970, 2021 | 29 | 2021 |
| Modeling SARS-CoV-2: comparative pathology in rhesus macaque and Golden Syrian hamster models S Choudhary, I Kanevsky, S Yildiz, RS Sellers, KA Swanson, T Franks, ... Toxicologic pathology 50 (3), 280-293, 2022 | 28 | 2022 |
| Suppression of JAK-STAT signaling by Epstein-Barr virus tegument protein BGLF2 through recruitment of SHP1 phosphatase and promotion of STAT2 degradation S Jangra, A Bharti, WY Lui, V Chaudhary, MG Botelho, KS Yuen, DY Jin Journal of virology 95 (20), 10.1128/jvi. 01027-21, 2021 | 26 | 2021 |
